학술논문
A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT
Document Type
Article
Author
Patil, S.; Linge, A.; Lohaus, F.; Tinhofer, I.; Budach, V.; Guberina, M.; Stuschke, M.; Balermpas, P.; von der Grün, J.; Schäfer, H.; Grosu, A.-L.; Abdollahi, A.; Debus, J.; Ganswindt, U.; Belka, C.; Pigorsch, S.; Combs, S.E.; Boeke, S.; Zips, D.; Jöhrens, K.; Baretton, G.B.; Baumann, M.; Krause, M.; Löck, S.; Hiepe, H.; Kemper, M.; Nowak, A.; Haim, D.; Grosser, M.; Gudziol, V.
Source
In: Cancers . (Cancers, June-2 2022, 14(12))
Subject
Language
English
ISSN
20726694